drugset / Trial / NCT06276569

Efficacy and Safety of Sivelestat in Preventing Postoperative Acute Lung Injury or Acute Respiratory Distress Syndrome After Cardiac Surgery

NCT06276569

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of this study is to assess the effectiveness and safety of sivelestat sodium in preventing acute lung injury and/or acute respiratory distress syndrome (ALI/ARDS) following cardiac surgery, with the objective of providing evidence-based support for its clinical application.

Timeline

Start
2024-02-18
Primary completion
2025-04-30
Completion
2025-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Sivelestat Small molecule 4.8 mg/kg Intravenous

Indications